Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-25-272616·DiaMedica Therapeutics Inc.
Schedule 13G ownership disclosure
DiaMedica Therapeutics Inc
Voting Common Shares, no par value · CUSIP: 25253X207
Event date: 2025-09-30
- Filing-level shares
- 4,958,823
- Percent of class
- 9.6%
- Richard Jacinto II
Shares: 4,958,823 · Class: 9.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-272616
- Form type
- SCHEDULE 13G/A
- Filer
- DiaMedica Therapeutics Inc.
- CIK
- CIK 1401040
- Filed
- Nov 07, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership